眉间皱纹的临床试验
总计10000个结果
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Second Affiliated Hospital, School of Medicine,...Women's Hospital School Of Medicine Zhejiang University; Zhejiang Provincial People's Hospital; Huizhou Municipal Central Hospital 和其他合作者招聘中
-
Shanghai Hengrui Pharmaceutical Co., Ltd.主动，不招人
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.主动，不招人
-
Duke UniversityUnited States Department of Defense完全的
-
State Institution "Republican Scientific and Practical...完全的
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research Consortium完全的
-
Seagen Inc.完全的
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline完全的HER2-Positive Early Stage Breast Cancer美国
-
First Affiliated Hospital Xi'an Jiaotong University未知
-
Institut Cancerologie de l'Ouest主动，不招人
-
University College, LondonEuropean Union完全的
-
Novartis PharmaceuticalsChugai Pharmaceutical完全的
-
Boehringer Ingelheim完全的乳腺肿瘤美国, 澳大利亚, 香港, 大韩民国, 泰国, 突尼斯, 英国
-
University Health Network, TorontoCanadian Breast Cancer Foundation完全的
-
University of Michigan Rogel Cancer CenterGenentech, Inc.完全的
-
Novartis PharmaceuticalsChugai Pharmaceutical完全的
-
Regione LombardiaMario Negri Institute for Pharmacological Research; Istituto Clinico Humanitas未知
-
Mayo Clinic招聘中解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 0 期乳腺癌解剖学 AJCC v8美国
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 浸润性乳腺小叶癌 | 转移性乳腺癌小叶癌美国
-
M.D. Anderson Cancer Center撤销解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 转移性乳腺癌 | 激素受体阳性乳腺癌 | 转移性 HER2 阴性乳腺癌美国
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI)终止
-
Relay Therapeutics, Inc.招聘中乳腺癌 | 晚期乳腺癌 | 转移性乳腺癌 | 实体瘤，成人 | HER2 阴性乳腺癌 | 不可切除的实体瘤 | PIK3CA突变美国, 西班牙, 澳大利亚, 法国, 意大利
-
Memorial Sloan Kettering Cancer Center主动，不招人
-
Mayo Clinic终止解剖学 I 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8美国
-
Fondazione Michelangelo完全的
-
George Washington UniversityImmutep S.A.S.尚未招聘乳腺癌 | HER 2 阴性乳腺癌 | HR 阳性/HER-2 阴性乳腺癌 | 阶段1-3